A Study of Tadalafil in Men With Benign Prostatic Hyperplasia Symptoms Who Are Being Treated With Alpha Blockers
type: MedicalStudy
description: A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Design Study to Evaluate the Safety and Efficacy of Daily Tadalafil for 12 Weeks in Men With Signs and Symptoms of Benign Prostatic Hyperplasia on Concomitant Alpha1-Adrenergic Blocker Therapy
status: COMPLETED
study design: INTERVENTIONAL
phase: PHASE3
start date: 2009-03
end date: 2009-12
license: https://creativecommons.org/publicdomain/zero/1.0/
source: https://clinicaltrials.gov/study/NCT00848081
source organization: US National Library of Medicine
publisher: AI Analytics
sponsor: Eli Lilly and Company
study subject: Benign Prostatic Hyperplasia
keywords: PHASE3
keywords: INTERVENTIONAL
keywords: COMPLETED
keywords: Benign Prostatic Hyperplasia

AI Analytics
type: Organization